Flávia De Angelis

Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer

Leena Gandhi, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · New England Journal of Medicine · 2018 · 6.6K citations · Full text

Medicine, Oncology, Pharmacology +16

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

Abstract CT043: Outcomes among patients (pts) with metastatic nonsquamous NSCLC with liver metastases or brain metastases treated with pembrolizumab (pembro) plus pemetrexed-platinum: Results from the KEYNOTE-189 study

Marina Chiara Garassino, Shirish M. Gadgeel, Emilio Esteban et al. · Cancer Research · 2019 · 23 citations

Medicine, Oncology, Pharmacotherapy +16

Health-related quality of life (HRQoL) in the KEYNOTE-189 study of pembrolizumab (pembro) or placebo (pbo) + pemetrexed (pem) + platinum (plt) for metastatic NSCLC.

Marina Chiara Garassino, Delvys Rodríguez‐Abreu, Shirish M. Gadgeel et al. · Journal of Clinical Oncology · 2018 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Ten ways to get a grip on designing and implementing a competency-based medical education training program

Tina Hsu, Flávia De Angelis, Sohaib Al-Asaaed et al. · Canadian Medical Education Journal · 2021 · 13 citations · Full text

Education, Curriculum, Medical Education +11